Atlas Trials

Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

Clinical trial NCT00981526 · COMPLETED

Trial details

NCT number
NCT00981526
Sponsor
University of Massachusetts, Worcester
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2009-03-01
Primary completion
2012-05-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.